|
⚲
|
| RA Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001481512 |
| Sale | 2010-02-12 ($27.6 M Offered, $10.3 M Sold) |
| Fund | |
| Phone | 6175877806 |
| Address | 222 Berkeley Street Boston, 02116 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Douglas Treco | |
| Edward Mathers | |
| James Broderick | |
| Theodore Laufik | |
| Lauren Silverman |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
LASP Equity Fund, LP
✚
|
0.0 | |
|
Lasserre Didier
✚
|
0.0 | |
|
Lassiter Wright III
✚
|
0.0 | |
|
Lavallee Heather H.
✚
|
0.0 | |
|
DBL Partners TIAB 2018, L.P.
✚
|
0.0 | |
|
Leemon Daniel O
✚
|
0.0 | |
|
Lee Patrick
✚
|
0.0 | |
|
Leerink Transformation Investors I L.P.
✚
|
0.0 | |
|
Ancora Catalyst SPV I SPC Ltd. - Segregated Portfolio F
✚
|
0.0 | |
|
Lane John T
✚
|
0.0 |